Variant report

Variant	esv3342426
Chromosome Location	chr17:15688677-15690975
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:51)
CpG islands
(count:366)
Chromatin interactive
region (count:0)
LncRNA
region (count:0)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:51 , 50 per page) page: 1 2

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	CTCF	chr17:15689399-15689488	Kidney_OC	kidney:	n/a	n/a
2	CTCF	chr17:15690268-15690448	A549	lung:	n/a	n/a
3	FOXA2	chr17:15689329-15689568	A549	lung:	n/a	n/a
4	GABPA	chr17:15689256-15689526	A549	lung:	n/a	n/a
5	GABPA	chr17:15689256-15689571	A549	lung:	n/a	n/a
6	GABPA	chr17:15689362-15689578	SK-N-SH	brain:	n/a	n/a
7	MYC	chr17:15690213-15690264	MCF-7	breast:	n/a	n/a
8	MYC	chr17:15689356-15689483	HUVEC	blood vessel:	n/a	n/a
9	MYC	chr17:15689876-15690057	MCF-7	breast:	n/a	n/a
10	POLR2A	chr17:15689443-15689533	A549	lung:	n/a	n/a
11	POLR2A	chr17:15690114-15690139	MCF-7	breast:	n/a	n/a
12	POLR2A	chr17:15690168-15690285	MCF-7	breast:	n/a	n/a
13	POLR2A	chr17:15689863-15690041	Gliobla	brain:	n/a	n/a
14	POLR2A	chr17:15689421-15689556	A549	lung:	n/a	n/a
15	POLR2A	chr17:15690803-15690850	Gliobla	brain:	n/a	n/a
16	POLR2A	chr17:15690264-15690301	A549	lung:	n/a	n/a
17	POLR2A	chr17:15689298-15689539	H1-hESC	embryonic stem cell:	n/a	n/a
18	POLR2A	chr17:15689325-15690090	MCF-7	breast:	n/a	n/a
19	POLR2A	chr17:15690152-15690251	Gliobla	brain:	n/a	n/a
20	POLR2A	chr17:15689760-15690104	H1-hESC	embryonic stem cell:	n/a	n/a
21	POLR2A	chr17:15689368-15689564	MCF-7	breast:	n/a	n/a
22	POLR2A	chr17:15690760-15690791	MCF-7	breast:	n/a	n/a
23	POLR2A	chr17:15689892-15689902	H1-hESC	embryonic stem cell:	n/a	n/a
24	POLR2A	chr17:15689381-15689547	ECC-1	luminal epithelium:	n/a	n/a
25	POLR2A	chr17:15690677-15690793	K562	blood:	n/a	n/a
26	POLR2A	chr17:15689765-15689780	H1-hESC	embryonic stem cell:	n/a	n/a
27	POLR2A	chr17:15690794-15690842	MCF-7	breast:	n/a	n/a
28	POLR2A	chr17:15689432-15689552	Gliobla	brain:	n/a	n/a
29	POLR2A	chr17:15689845-15690072	H1-hESC	embryonic stem cell:	n/a	n/a
30	POLR2A	chr17:15689612-15690060	H1-hESC	embryonic stem cell:	n/a	n/a
31	POLR2A	chr17:15690388-15690423	A549	lung:	n/a	n/a
32	POLR2A	chr17:15689398-15689745	H1-hESC	embryonic stem cell:	n/a	n/a
33	POLR2A	chr17:15689415-15689586	A549	lung:	n/a	n/a
34	POLR2A	chr17:15690364-15690395	Gliobla	brain:	n/a	n/a
35	POLR2A	chr17:15689462-15689582	A549	lung:	n/a	n/a
36	POLR2A	chr17:15690338-15690343	Gliobla	brain:	n/a	n/a
37	POLR2A	chr17:15689415-15689548	MCF-7	breast:	n/a	n/a
38	POLR2A	chr17:15690065-15690186	MCF-7	breast:	n/a	n/a
39	POLR2A	chr17:15690620-15690696	MCF-7	breast:	n/a	n/a
40	REST	chr17:15690685-15690837	HepG2	liver:	n/a	n/a
41	REST	chr17:15690602-15690950	U87	brain:	n/a	n/a
42	REST	chr17:15690670-15690896	PFSK-1	brain:	n/a	n/a
43	REST	chr17:15690686-15690929	HepG2	liver:	n/a	n/a
44	REST	chr17:15689857-15690195	H1-hESC	embryonic stem cell:	n/a	n/a
45	REST	chr17:15689938-15690146	SK-N-SH	brain:	n/a	n/a
46	REST	chr17:15690680-15690960	H1-hESC	embryonic stem cell:	n/a	n/a
47	REST	chr17:15690744-15690965	H1-hESC	embryonic stem cell:	n/a	n/a
48	REST	chr17:15689857-15690245	H1-hESC	embryonic stem cell:	n/a	n/a
49	REST	chr17:15690740-15690912	HepG2	liver:	n/a	n/a
50	SPI1	chr17:15689366-15689501	K562	blood:	n/a	n/a

(count:366 , 50 per page) page: 1 2 3 4 5 6 7 8

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr17:15689920-15689970	PANC-1	pancreas:	n/a
2	chr17:15689920-15689970	CMK	blood:	n/a
3	chr17:15690181-15690231	SK-N-MC	brain:	n/a
4	chr17:15690132-15690182	HMEC	breast:	n/a
5	chr17:15689091-15689141	HEK293	kidney:	embryo
6	chr17:15690713-15690763	PANC-1	pancreas:	n/a
7	chr17:15690713-15690763	H1-hESC	embryonic stem cell:	embryo
8	chr17:15690713-15690763	Hepatocyte	liver:	n/a
9	chr17:15690132-15690182	HCM	heart:	n/a
10	chr17:15690713-15690763	ProgFib	skin:	n/a
11	chr17:15690181-15690231	HMEC	breast:	n/a
12	chr17:15690713-15690763	PrEC	prostate:	n/a
13	chr17:15690132-15690182	GM06990	blood:	n/a
14	chr17:15689920-15689970	BE2_C	brain:	n/a
15	chr17:15689920-15689970	HCF	heart:	n/a
16	chr17:15689957-15690007	A549	lung:	n/a
17	chr17:15690132-15690182	ProgFib	skin:	n/a
18	chr17:15689957-15690007	PrEC	prostate:	n/a
19	chr17:15690132-15690182	U87	brain:	n/a
20	chr17:15690713-15690763	HepG2	liver:	n/a
21	chr17:15690713-15690763	HCPEpiC	choroid plexus:	n/a
22	chr17:15690181-15690231	AG09319	gingival:	n/a
23	chr17:15689091-15689141	HEEpiC	esophagus:	n/a
24	chr17:15689957-15690007	HEK293	kidney:	embryo
25	chr17:15689957-15690007	HMEC	breast:	n/a
26	chr17:15690713-15690763	HL-60	blood:	n/a
27	chr17:15689957-15690007	AG09309	skin:	n/a
28	chr17:15689091-15689141	HCPEpiC	choroid plexus:	n/a
29	chr17:15689091-15689141	HepG2	liver:	n/a
30	chr17:15690132-15690182	Hepatocyte	liver:	n/a
31	chr17:15689091-15689141	HUVEC	blood vessel:	n/a
32	chr17:15689920-15689970	HAEpiC	amniotic membrane:	n/a
33	chr17:15690713-15690763	HAEpiC	amniotic membrane:	n/a
34	chr17:15689091-15689141	HAEpiC	amniotic membrane:	n/a
35	chr17:15689957-15690007	HCF	heart:	n/a
36	chr17:15689920-15689970	AG10803	skin:	n/a
37	chr17:15690713-15690763	MCF-7	breast:	n/a
38	chr17:15689957-15690007	MCF-7	breast:	n/a
39	chr17:15689091-15689141	SK-N-SH	brain:	n/a
40	chr17:15689091-15689141	AG04450	lung:	fetal
41	chr17:15690181-15690231	MCF10A-Er-Src	breast:	n/a
42	chr17:15690132-15690182	PFSK-1	brain:	n/a
43	chr17:15689920-15689970	HRCEpiC	kidney:	n/a
44	chr17:15689957-15690007	NHBE	bronchial:	n/a
45	chr17:15689920-15689970	IMR90	lung:	fetal
46	chr17:15690132-15690182	ECC-1	luminal epithelium:	n/a
47	chr17:15690132-15690182	HRPEpiC	eye:	n/a
48	chr17:15689920-15689970	GM12891	blood:	n/a
49	chr17:15689091-15689141	HRPEpiC	eye:	n/a
50	chr17:15689920-15689970	Caco-2	colon:	n/a

No data

Variant related genes	Relation type
MEIS3P1	TF binding region
MEIS3P1	CpG island

Extended variants
information (count: 87 )
Associated
traits (count: 128 )

Variant overlapped rSNPs/rCNVs (count:87 , 50 per page) page: 1 2

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs187244907	chr17:15688678-15688679	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
2	rs77059935	chr17:15688743-15688744	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
3	rs561465427	chr17:15688771-15688772	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
4	rs376159529	chr17:15688776-15688777	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
5	rs149561616	chr17:15688817-15688818	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
6	rs369310014	chr17:15688824-15688825	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
7	rs35740169	chr17:15688845-15688846	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
8	rs369291780	chr17:15688862-15688863	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
9	rs543920150	chr17:15688895-15688896	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
10	rs146915232	chr17:15688922-15688923	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
11	rs370244818	chr17:15688928-15688929	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
12	rs373468503	chr17:15688988-15688989	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
13	rs532510439	chr17:15689097-15689098	Enhancers Active TSS Weak transcription Flanking Active TSS	CpG island	1 gene(s)	Overlapped CNVs	n/a
14	rs552306110	chr17:15689125-15689126	Enhancers Active TSS Weak transcription Flanking Active TSS	CpG island	1 gene(s)	Overlapped CNVs	n/a
15	rs62070978	chr17:15689172-15689173	Enhancers Active TSS Weak transcription Flanking Active TSS	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
16	rs143234805	chr17:15689204-15689205	Enhancers Active TSS Weak transcription Flanking Active TSS Bivalent/Poised TSS	n/a	n/a	Overlapped CNVs	n/a
17	rs527584459	chr17:15689250-15689251	Enhancers Active TSS Weak transcription Flanking Active TSS Bivalent/Poised TSS	n/a	n/a	Overlapped CNVs	n/a
18	rs547327922	chr17:15689286-15689287	Enhancers Active TSS Weak transcription Flanking Active TSS Bivalent/Poised TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
19	rs567108240	chr17:15689299-15689300	Enhancers Active TSS Weak transcription Flanking Active TSS Bivalent/Poised TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
20	rs563553079	chr17:15689311-15689312	Enhancers Active TSS Weak transcription Flanking Active TSS Bivalent/Poised TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
21	rs536069034	chr17:15689343-15689344	Enhancers Active TSS Weak transcription Flanking Active TSS Bivalent/Poised TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
22	rs530078895	chr17:15689407-15689408	Active TSS Enhancers Weak transcription Bivalent/Poised TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
23	rs549819871	chr17:15689432-15689433	Active TSS Enhancers Weak transcription Bivalent/Poised TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
24	rs372987670	chr17:15689448-15689449	Active TSS Enhancers Weak transcription Bivalent/Poised TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
25	rs576213912	chr17:15689494-15689495	Active TSS Enhancers Weak transcription Bivalent/Poised TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
26	rs62070979	chr17:15689515-15689516	Active TSS Enhancers Weak transcription Bivalent/Poised TSS	TF binding region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
27	rs558267653	chr17:15689725-15689726	Active TSS Enhancers Weak transcription Bivalent/Poised TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
28	rs192069593	chr17:15689876-15689877	Active TSS Flanking Active TSS Enhancers Weak transcription Bivalent/Poised TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
29	rs61738282	chr17:15689885-15689886	Active TSS Flanking Active TSS Enhancers Weak transcription Bivalent/Poised TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
30	rs533073	chr17:15689939-15689940	Active TSS Flanking Active TSS Enhancers Weak transcription Bivalent/Poised TSS	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
31	rs555338704	chr17:15689969-15689970	Active TSS Flanking Active TSS Enhancers Weak transcription Bivalent/Poised TSS	n/a	n/a	Overlapped CNVs	n/a
32	rs62070980	chr17:15690046-15690047	Active TSS Flanking Active TSS Weak transcription Bivalent/Poised TSS Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
33	rs544052541	chr17:15690066-15690067	Active TSS Flanking Active TSS Weak transcription Bivalent/Poised TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
34	rs563769513	chr17:15690081-15690082	Active TSS Flanking Active TSS Weak transcription Bivalent/Poised TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
35	rs577276160	chr17:15690101-15690102	Active TSS Flanking Active TSS Weak transcription Bivalent/Poised TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
36	rs546132710	chr17:15690113-15690114	Active TSS Flanking Active TSS Weak transcription Bivalent/Poised TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
37	rs199962206	chr17:15690123-15690124	Active TSS Flanking Active TSS Weak transcription Bivalent/Poised TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
38	rs528500678	chr17:15690160-15690161	Active TSS Flanking Active TSS Weak transcription Bivalent/Poised TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
39	rs540903657	chr17:15690164-15690165	Active TSS Flanking Active TSS Weak transcription Bivalent/Poised TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
40	rs560869857	chr17:15690178-15690179	Active TSS Flanking Active TSS Weak transcription Bivalent/Poised TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
41	rs61731176	chr17:15690181-15690182	Active TSS Flanking Active TSS Weak transcription Bivalent/Poised TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
42	rs376068178	chr17:15690211-15690212	Weak transcription Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
43	rs59447254	chr17:15690215-15690216	Weak transcription Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
44	rs62070981	chr17:15690220-15690221	Weak transcription Active TSS Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
45	rs62070982	chr17:15690281-15690282	Weak transcription Active TSS Enhancers	n/a	n/a	Overlapped CNVs	mRNA abundance
46	rs200526826	chr17:15690295-15690296	Weak transcription Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
47	rs569684044	chr17:15690309-15690310	Weak transcription Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
48	rs150739886	chr17:15690369-15690370	Weak transcription Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
49	rs552293175	chr17:15690380-15690381	Weak transcription Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
50	rs374560624	chr17:15690394-15690395	Weak transcription Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:128)

Disease	PMID	Source
Burkitt''s lymphoma	18698080	CNVD
Breast cancer	17603634	CNVD
Melanoma	18172304	CNVD
Glioblastoma multiforme	19435819	CNVD
Non-small cell lung cancer	19010865	CNVD
Oral squamous cell carcinoma	17134496	CNVD
Colorectal cancer	16774939	CNVD
Hepatocellular carcinoma	18803288	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Burkitt''s lymphoma	19759907	CNVD
Wilms tumour	21544195	CNVD
Esophageal adenocarcinoma	18519675	CNVD
lymphocytic leukemia	21291569	CNVD
Acute lymphoblastic leukemia	21390130	CNVD
Medulloblastoma	21979893	CNVD
Breast cancer	16608533	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Chordoma	21602918	CNVD
Miller-Dieker syndrome	22283845	CNVD
Non-syndromic sensorineural hearing loss	17457615	CNVD
Cancer	22429812	CNVD
Chronic lymphocytic leukemia	21795749	CNVD
Ewing''s sarcoma	21437220	CNVD
Follicular lymphoma	19010834	CNVD
Colorectal cancer	20709793	CNVD
Acute myeloid leukemia	16864856	CNVD
Endometrial cancer	22040021	CNVD
Paraganglioma	21461997	CNVD
Pheochromocytoma	21461997	CNVD
Breast cancer	22028636	CNVD
Breast cancer	20837533	CNVD
Astrocytoma	17387387	CNVD
Breast cancer	21264507	CNVD
Hepatocellular carcinoma	22174799	CNVD
Medulloblastoma	21292688	CNVD
colon cancer	17210682	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Basal cell lymphoma	17053054	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Cancer	16751803	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Colorectal cancer	19359472	CNVD
Embryonal rhabdomyosarcoma	16790082	CNVD
Chronic lymphocytic leukemia	17971485	CNVD
Basal cell lymphoma	17170743	CNVD
Breast cancer	16461572	CNVD
Colorectal cancer	16272173	CNVD
Follicular lymphoma	17170743	CNVD
Human rectal carcinomas	16397240	CNVD
Breast cancer	17133270	CNVD
Chronic lymphocytic leukemia	18922857	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Glioblastoma multiforme	21080181	CNVD
Ovarian cancer	22174824	CNVD
Moyamoya disease	22323933	CNVD
small cell lung cancer	20016488	CNVD
Acute myeloid leukemia	20729466	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Acute promyelocytic leukemia	19109227	CNVD
Urothelial carcinoma	21177765	CNVD
Acute myeloid leukemia	21251322	CNVD
Myelodysplastic syndrome	21251322	CNVD
Cancer	20164919	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Acute myeloid leukemia	20724749	CNVD
Non-syndromic sensorineural hearing loss	21030649	CNVD
Acute myeloid leukemia	17237825	CNVD
Colorectal cancer	21645411	CNVD
HIV/AIDS	22844521	CNVD
Psoriasis	22844521	CNVD
Rheumatoid arthritis	22844521	CNVD
Sclerosis systemic	22844521	CNVD
Systemic lupus erythematosus	22844521	CNVD
HIV/AIDS	17953491	CNVD
HIV/AIDS	20877625	CNVD
Immune disease	21076436	CNVD
Rheumatoid arthritis	17953491	CNVD
Type 1 diabetes	17953491	CNVD
HIV/AIDS	15637236	CNVD
Prostate cancer	18632612	CNVD
Lung cancer	18438408	CNVD
Ovarian cancer	21781307	CNVD
Autism	22495311	CNVD
Breast cancer	20668451	CNVD
Cancer	20668451	CNVD
Lung cancer	20668451	CNVD
Ovarian cancer	20668451	CNVD
Pancreas cancer	20668451	CNVD
Prostate cancer	20668451	CNVD
Neurofibromatosis	18196300	CNVD
Adenoid cystic carcinoma	18332873	CNVD
Multiple myeloma	16616336	CNVD
Multiple myeloma	17550852	CNVD
Breast cancer	21509527	CNVD
Pancreatic cancer	21811587	CNVD
Autism	17322880	CNVD
Hereditary neuropathy with liability to pressure palsy	19521722	CNVD
Schizophrenia	19571808	CNVD
Schizophrenia	19955444	CNVD
Charcot-marie-tooth disease	18787571	CNVD
Breast cancer	20409316	CNVD
Autism	18414403	CNVD
Breast cancer	17001317	CNVD
Rhabdomyosarcoma	16790082	CNVD
Myelofibrosis	22110671	CNVD
Peripheral neuropathy	21193943	CNVD
Schizophrenia	20587603	CNVD
Schizophrenia	22958593	CNVD
Cutaneous T-cell lymphoma	21881587	CNVD
Malignant fibrous histiocytomas	21085701	CNVD
Ovarian cancer	20844748	CNVD
Barrett''s adenocarcinoma	18663352	CNVD
Charcot-marie-tooth disease	16463004	CNVD
Osteosarcoma	22292074	CNVD
Charcot	16760730	CNVD
Mental retardation	17901693	CNVD
ovarian endometriomas	16273235	CNVD
Breast cancer	21858162	CNVD
Ovarian cancer	21720365	CNVD
Acute lymphoblastic leukemia	21339820	CNVD
Breast cancer	17142309	CNVD
Pancreatic ductal adenocarcinoma	19077451	CNVD
Autism	22102821	CNVD
Gastric cancer	18160780	CNVD
Non-syndromic sensorineural hearing loss	19212409	CNVD
Breast cancer	22522925	CNVD

Chromatin state (count:174 , 50 per page) page: 1 2 3 4

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr17:15686400-15689400	Weak transcription	Ganglion Eminence derived primary cultured neurospheres	brain
2	chr17:15686400-15689400	Weak transcription	Sigmoid Colon	Sigmoid Colon
3	chr17:15686600-15688800	Weak transcription	Fetal Muscle Trunk	muscle
4	chr17:15686600-15689000	Weak transcription	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
5	chr17:15686600-15689000	Weak transcription	Foreskin Melanocyte Primary Cells skin03	Skin
6	chr17:15686600-15689200	Weak transcription	Cortex derived primary cultured neurospheres	brain
7	chr17:15686600-15689200	Weak transcription	Foreskin Melanocyte Primary Cells skin01	Skin
8	chr17:15686600-15689200	Weak transcription	Fetal Adrenal Gland	Adrenal Gland
9	chr17:15686600-15689200	Weak transcription	Fetal Brain Female	brain
10	chr17:15686600-15689200	Weak transcription	Ovary	ovary
11	chr17:15686600-15689200	Weak transcription	Rectal Mucosa Donor 29	rectum
12	chr17:15686600-15689200	Weak transcription	Right Ventricle	heart
13	chr17:15686600-15689200	Weak transcription	HSMM	muscle
14	chr17:15686600-15689200	Weak transcription	NHLF	lung
15	chr17:15686600-15689400	Weak transcription	Foreskin Fibroblast Primary Cells skin01	Skin
16	chr17:15686600-15689400	Weak transcription	Aorta	Aorta
17	chr17:15686600-15689400	Weak transcription	Colonic Mucosa	Colon
18	chr17:15686600-15689400	Weak transcription	Fetal Muscle Leg	muscle
19	chr17:15686600-15689400	Weak transcription	Left Ventricle	heart
20	chr17:15686600-15689400	Weak transcription	HMEC	breast
21	chr17:15686600-15689600	Weak transcription	Brain Germinal Matrix	brain
22	chr17:15686600-15689600	Weak transcription	Esophagus	oesophagus
23	chr17:15686600-15689600	Weak transcription	Lung	lung
24	chr17:15686600-15689600	Weak transcription	Pancreas	Pancrea
25	chr17:15686600-15689600	Weak transcription	Rectal Mucosa Donor 31	rectum
26	chr17:15686600-15689600	Weak transcription	Rectal Smooth Muscle	rectum
27	chr17:15686600-15689600	Weak transcription	Stomach Smooth Muscle	stomach
28	chr17:15686600-15689800	Weak transcription	Placenta	Placenta
29	chr17:15686600-15690600	Weak transcription	Primary hematopoietic stem cells	blood
30	chr17:15686600-15691400	Weak transcription	Gastric	stomach
31	chr17:15686800-15689000	Weak transcription	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
32	chr17:15686800-15689000	Weak transcription	Adipose Nuclei	Adipose
33	chr17:15686800-15689200	Weak transcription	Osteobl	bone
34	chr17:15686800-15689400	Weak transcription	Pancreatic Islets	Pancreatic Islet
35	chr17:15687000-15689400	Weak transcription	Duodenum Mucosa	Duodenum
36	chr17:15687600-15689200	Enhancers	Fetal Stomach	stomach
37	chr17:15687800-15689400	Weak transcription	Breast Myoepithelial Primary Cells	Breast
38	chr17:15687800-15689400	Weak transcription	Psoas Muscle	Psoas
39	chr17:15687800-15689600	Weak transcription	Colon Smooth Muscle	Colon
40	chr17:15687800-15690000	Enhancers	Primary monocytes fromperipheralblood	blood
41	chr17:15688000-15689200	Weak transcription	Fetal Heart	heart
42	chr17:15688200-15689200	Weak transcription	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
43	chr17:15688200-15689200	Weak transcription	Duodenum Smooth Muscle	Duodenum
44	chr17:15688200-15689200	Weak transcription	Right Atrium	heart
45	chr17:15688200-15689200	Weak transcription	Monocytes-CD14+_RO01746	blood
46	chr17:15688200-15689400	Weak transcription	IMR90 fetal lung fibroblasts Cell Line	lung
47	chr17:15688200-15689600	Weak transcription	Fetal Lung	lung
48	chr17:15688400-15689200	Weak transcription	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
49	chr17:15688600-15689200	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Female	--
50	chr17:15688600-15689200	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Male	--

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links